Editas Medicine (EDIT) PT Raised to $4 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Yanan Zhu raised the price target on Editas Medicine (NASDAQ: EDIT) to $4.00 (from $3.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
